Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy

NCT02002884 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

351

Enrollment

INDUSTRY

Sponsor class

Conditions

Cerebral Palsy
Spasticity

Interventions

DRUG: IncobotulinumtoxinA (8 Units per kg body weight)
DRUG: IncobotulinumtoxinA (6 Units per kg body weight)
DRUG: IncobotulinumtoxinA (2 Units per kg body weight)

Sponsor

Merz Pharmaceuticals GmbH